EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer

Jingjing Guo, Baijie Tang, Jing Fu, Xuan Zhu, Wenlong Xie, Nan Wang, Zhiyong Ding, Zhentao Song, Yue Yang, Gang Xu, Xue Xiao

Cellular Oncology · 2024

DOI: 10.1007/s13402-023-00885-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Jingjing Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu,…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Mismatch Repair, Gene Expression Profiling, Tumor Microenvironment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Tumors bearing mismatch repair deficiency (MMRd) are characterized by a high load of neoantigens and are believed to trigger immunogenic reactions upon immune checkpoint blockade treatment such as anti-PD-1/PD-L1 therapy. However, the mechanisms are still ill-defined, as multiple cancers with MMRd exhibit variable responses to immune checkpoint inhibitors (ICIs). In endometrial cancer (EC), a distinct tumor microenvironment (TME) exists that may correspond to treatment-related efficacies. We aimed to characterize EC patients with aberrant MMR pathways to identify molecular subtypes predisposed to respond to ICI therapies.

Methods

We applied digital spatial profiling, a high-plex spatial transcriptomic approach covering over 1,800 genes, to obtain a highly resolved TME landscape in 45 MMRd-EC patients. We cross-validated multiple biomarkers identified using immunohistochemistry and multiplexed immunofluorescence using in-study and independent cohorts totaling 123 MMRd-EC patients and validated our findings using external TCGA data from microsatellite instability endometrial cancer (MSI-EC) patients.

Results

High-plex spatial profiling identified a 14-gene signature in the MMRd tumor-enriched regions stratifying tumors into “hot”, “intermediate” and “cold” groups according to their distinct immune profiles, a finding highly consistent with the corresponding CD8 + T-cell infiltration status. Our validation studies further corroborated an existing coregulatory network involving HLA class I and DNMT3A potentially bridged through dynamic crosstalk incorporating CCL5.

Conclusion

Our study confirmed the heterogeneous TME status within MMRd-ECs and showed that these ECs can be stratified based on potential biomarkers such as HLA class I, DNMT3A and CD8 in pathological settings for improved ICI therapeutic efficacy in this subset of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA Mismatch RepairGene Expression ProfilingTumor MicroenvironmentHistocompatibility Antigens Class IDNA Methyltransferase 3AHumansFemaleCD8 AntigensGene Expression Regulation, NeoplasticCD8-Positive T-LymphocytesMiddle AgedDNA (Cytosine-5-)-MethyltransferasesTranscriptomeMicrosatellite InstabilityAged

Stichwörter der Autor:innen

DNMT3ADigital spatial profilingEndometrial cancerHLA class IImmunotherapyMismatch repair deficiency (MMRd)

Substanzen

Histocompatibility Antigens Class IDNA Methyltransferase 3ADNMT3A protein, humanCD8 AntigensDNA (Cytosine-5-)-Methyltransferases

Autor:innen und Institutionen

  • Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • School of Medical and Life Sciences, Chengdu University of TCM, Chengdu, China.
  • Mills Institute for Personalized Cancer Care, Jinan, China.
  • Department of Pathology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. xiaoxue@med.uestc.edu.cn.

Zitieren

APA

Guo, J., Tang, B., Fu, J., Zhu, X., Xie, W., Wang, N., Ding, Z., Song, Z., Yang, Y., Xu, G., & Xiao, X. (2024). High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer. Cellular Oncology. https://doi.org/10.1007/s13402-023-00885-8

Vancouver

Guo J, Tang B, Fu J, Zhu X, Xie W, Wang N, et al. High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer. Cellular Oncology. 2024. doi:10.1007/s13402-023-00885-8

BibTeX
@article{Guo2024,
  author = {Guo, Jingjing and Tang, Baijie and Fu, Jing and Zhu, Xuan and Xie, Wenlong and Wang, Nan and Ding, Zhiyong and Song, Zhentao and Yang, Yue and Xu, Gang and Xiao, Xue},
  title = {High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-023-00885-8}
}
Kostenlos starten →